Doctors raise alarm about women’s safety in domestic violence study

Some partners of men participating in a trial of an SSRI to reduce their violence have complained of increased abuse

Doctors advocating for women experiencing domestic violence have called for a moratorium on a world-first trial of an antidepressant to reduce offences among men with a history of impulsivity and violence. 

It has been claimed that at least three current or former partners of men enrolled in the ReINVEST trial underway in NSW have reported increased violence since it began.

The randomised controlled trial is comparing outcomes for men with histories of violent offending, including domestic violence, after 12 months on sertraline 100mg daily or placebo.

The hypothesis for the study, led by UNSW Sydney’s school of population health, is that given the association between poor impulse control and aggression, boosting serotonin neurotransmission may help offenders manage their impulsivity.